Showing 1 - 6 results of 6 for search 'Beibei Fu', query time: 0.02s Refine Results
  1. 1
    Extracellular vesicles from adipose-derived mesenchymal stem cells alleviate acute lung injury via the CBL/AMPK signaling pathway

    Extracellular vesicles from adipose-derived mesenchymal stem cells alleviate acute lung injury via the CBL/AMPK signaling pathway by Yan Xiong, Lulu Wang, Bohao Li, Beibei Fu, Zhou Sha, Jin Liu, Rong Tian, Rui Yao, Feng Lin, Zixuan Cong, Yongliang Du, Xiaoyuan Lin, Haibo Wu

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    SENP1-SIRT3 axis mediates glycolytic reprogramming to suppress inflammation during Listeria monocytogenes infection

    SENP1-SIRT3 axis mediates glycolytic reprogramming to suppress inflammation during Listeria monocytogenes infection by Yan Xiong, Yongliang Du, Feng Lin, Beibei Fu, Dong Guo, Zhou Sha, Rong Tian, Rui Yao, Lulu Wang, Zixuan Cong, Bohao Li, Xiaoyuan Lin, Haibo Wu

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Bacteroides Fragilis Transplantation Reverses Reproductive Senescence by Transporting Extracellular Vesicles Through the Gut‐Ovary Axis

    Bacteroides Fragilis Transplantation Reverses Reproductive Senescence by Transporting Extracellular Vesicles Through the Gut‐Ovary Axis by Yan Xiong, Xiaoxue Lu, Bohao Li, Shiyao Xu, Beibei Fu, Zhou Sha, Rong Tian, Rui Yao, Qian Li, Jingmin Yan, Dong Guo, Zixuan Cong, Yongliang Du, Xiaoyuan Lin, Haibo Wu

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles

    SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles by Ting Zhang, Jianyan Xu, Junzhao Yin, Yun Gao, Hanwen Zheng, Beibei Fu, Jiakang Sun, Zhibin Xu, Shiwei Tu, Yuchang Mao, Weiyun Wen, Bolei Qu, Lingfeng You, Zhendong Xue, Xing Sun, Dan Cao, Jun Feng, Min Hu, Feng He

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    SHR-A1811, a novel anti-HER2 antibody-drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles.

    SHR-A1811, a novel anti-HER2 antibody-drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles. by Ting Zhang, Jianyan Xu, Junzhao Yin, Yun Gao, Hanwen Zheng, Beibei Fu, Jiakang Sun, Zhibin Xu, Shiwei Tu, Yuchang Mao, Weiyun Wen, Bolei Qu, Lingfeng You, Zhendong Xue, Xing Sun, Dan Cao, Jun Feng, Min Hu, Feng He

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron

    A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron by Xiaoyuan Lin, Zhou Sha, Chunlin Zhang, Julia M. Adler, Ricardo Martin Vidal, Christine Langner, Beibei Fu, Yan Xiong, Meng Tan, Chen Jiang, Hao Zeng, Xiaokai Zhang, Qian Li, Jingmin Yan, Xiaoxue Lu, Shiwei Wang, Xuhu Mao, Dusan Kunec, Jakob Trimpert, Haibo Wu, Quanming Zou, Zhenglin Zhu

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: